Acquisitions, Mergers & PartnershipsMedical AMOrthopedic Implants

Zeda acquires The Orthopaedic Implant Company (OIC)

Enabling Zeda to produce OIC’s implant designs and provide accessible, high-value trauma implants to patients worldwide

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Zeda, an innovative healthcare solutions provider utilizing additive manufacturing technology, has acquired The Orthopaedic Implant Company (OIC), an orthopedic implant company recognized as a leader in value-based implants. This acquisition is a significant leap for Zeda in strengthening its commitment to revolutionizing the manufacturing and distribution of medical devices, globally.

OIC’s unparalleled expertise in value-based implants has made it a pioneer in delivering high-quality, cost-effective orthopedic devices. The acquisition enables Zeda to produce OIC’s time-tested implant designs – fortifying and accelerating its mission to provide accessible, high-value trauma implants to patients worldwide.

“The acquisition of OIC represents a pivotal moment for Zeda. Its leadership in value-based implants perfectly complements our additive manufacturing technologies that can deliver high-quality orthopedic devices and implants that are accessible to all patients, regardless of country and socioeconomic status. Together, our strengths and expertise will raise the standard of care globally and equitably for the world’s entire population,” said Shri Shetty, CEO of Zeda.

“We are proud to join forces with Zeda, a company that shares in our values and dedication to advancing access to critical orthopedic care because it can and should be done. Under Zeda, OIC will reach new heights in providing cost-effective, high-quality orthopedic solutions in the US and abroad,” said Itai Nemovicher, CEO and Co-Founder of The Orthopaedic Implant Company.

Under the terms of the acquisition by Zeda, OIC will operate worldwide as a Zeda Health company. The deal solidifies Zeda’s position in the global orthopedic industry as a company developing and using leading design and manufacturing technologies that push device design forward while drastically improving affordability and access to excellent care.

Last year, Zeda opened a new 75,000-square-foot facility in Cincinnati, Ohio, dedicated to providing cutting-edge manufacturing and nano-coating technologies. The new facility, expanded from its existing 16,000-square-foot facility, was built to provide substantially more capacity for growth and expanded capabilities to serve the exponential demand for advanced additive manufacturing in the company’s served markets.

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Edward Wakefield

Edward is a freelance writer and additive manufacturing enthusiast looking to make AM more accessible and understandable.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.